Lastly, Lorena et al. reported DAXX mRNA levels as increased in metastatic prostate cancer tissues but low in normal prostate glands, and increased DAXX expression was associated with higher tumor Gleason scores and lower patients’ OS [81]. This evidence concerns the gene DAXX and prostate carcinoma.